Literature DB >> 21880861

Symptom management in metastatic breast cancer.

William Irvin1, Hyman B Muss, Deborah K Mayer.   

Abstract

Approximately 40,000 women die as a result of breast cancer each year and many more live with advanced disease. When breast cancer recurs, the goals of treatment often shift from one of cure to controlling the disease for as long as possible while palliating symptoms interfering with the patient's functional status and quality of life. This requires ongoing discussions with the patient and family about the goals of care. Many symptoms depend on the site of metastasis, with bone being the most frequent, and commonly occur with fatigue, depression, insomnia, and pain. The purpose of this paper is to identify and provide an overview of the management of the most common symptoms in patients with breast cancer metastases.

Entities:  

Mesh:

Year:  2011        PMID: 21880861      PMCID: PMC3228166          DOI: 10.1634/theoncologist.2011-0159

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  86 in total

Review 1.  Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review.

Authors:  Ewan McNicol; Nathalie Horowicz-Mehler; Ruth A Fisk; Kyle Bennett; Maria Gialeli-Goudas; Priscilla W Chew; Joseph Lau; Daniel Carr
Journal:  J Pain       Date:  2003-06       Impact factor: 5.820

2.  Rehydration in the treatment of severe hypercalcaemia.

Authors:  D J Hosking; A Cowley; C A Bucknall
Journal:  Q J Med       Date:  1981

3.  Pulmonary lymphangitic metastases from breast carcinoma.

Authors:  H S Goldsmith; H D Bailey; E L Callahan; E J Beattie
Journal:  Arch Surg       Date:  1967-04

4.  The development of clinical guidelines on paracentesis for ascites related to malignancy.

Authors:  J Stephenson; J Gilbert
Journal:  Palliat Med       Date:  2002-05       Impact factor: 4.762

Review 5.  Management of dyspnea.

Authors:  Jay R Thomas; Charles F von Gunten
Journal:  J Support Oncol       Date:  2003 May-Jun

6.  Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis.

Authors:  David W Kissane; Brenda Grabsch; Anthony Love; David M Clarke; Sidney Bloch; Graeme C Smith
Journal:  Aust N Z J Psychiatry       Date:  2004-05       Impact factor: 5.744

Review 7.  Nebulised morphine for severe interstitial lung disease.

Authors:  R Polosa; A Simidchiev; E H Walters
Journal:  Cochrane Database Syst Rev       Date:  2002

Review 8.  Bisphosphonates and radiation therapy for palliation of metastatic bone disease.

Authors:  P J Hoskin
Journal:  Cancer Treat Rev       Date:  2003-08       Impact factor: 12.111

Review 9.  Diagnosis and management of central nervous system metastases from breast cancer.

Authors:  Eric L Chang; Simon Lo
Journal:  Oncologist       Date:  2003

10.  Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea.

Authors:  Amy P Abernethy; David C Currow; Peter Frith; Belinda S Fazekas; Annie McHugh; Chuong Bui
Journal:  BMJ       Date:  2003-09-06
View more
  31 in total

Review 1.  Systemic treatment approaches in her2-negative advanced breast cancer-guidance on the guidelines.

Authors:  A A Joy; M Ghosh; R Fernandes; M J Clemons
Journal:  Curr Oncol       Date:  2015-03       Impact factor: 3.677

Review 2.  Nasal cavity metastasis of breast cancer: a case report and review of the literature.

Authors:  Binqi Weng; Qinying Wang; San Lin; Yuyu Lu
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 3.  Evolution of breast cancer therapeutics: Breast tumour kinase's role in breast cancer and hope for breast tumour kinase targeted therapy.

Authors:  Haroon A Hussain; Amanda J Harvey
Journal:  World J Clin Oncol       Date:  2014-08-10

4.  miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2.

Authors:  Emanuel Kronski; Micol E Fiori; Ottavia Barbieri; Simonetta Astigiano; Valentina Mirisola; Peter H Killian; Antonino Bruno; Arianna Pagani; Francesca Rovera; Ulrich Pfeffer; Christian P Sommerhoff; Douglas M Noonan; Andreas G Nerlich; Laura Fontana; Beatrice E Bachmeier
Journal:  Mol Oncol       Date:  2014-01-16       Impact factor: 6.603

5.  Mechanoresponsive stem cells to target cancer metastases through biophysical cues.

Authors:  Linan Liu; Shirley X Zhang; Wenbin Liao; Henry P Farhoodi; Chi W Wong; Claire C Chen; Aude I Ségaliny; Jenu V Chacko; Lily P Nguyen; Mengrou Lu; George Polovin; Egest J Pone; Timothy L Downing; Devon A Lawson; Michelle A Digman; Weian Zhao
Journal:  Sci Transl Med       Date:  2017-07-26       Impact factor: 17.956

6.  Breast Cancer in Nepal: Current status and future directions.

Authors:  Mohan Giri; Mamata Giri; Rabin Jung Thapa; Bibhuti Upreti; Bijay Pariyar
Journal:  Biomed Rep       Date:  2018-02-05

7.  HER2 mediated de novo production of TGFβ leads to SNAIL driven epithelial-to-mesenchymal transition and metastasis of breast cancer.

Authors:  Parul Gupta; Sanjay K Srivastava
Journal:  Mol Oncol       Date:  2014-06-18       Impact factor: 6.603

8.  Functional benefits are sustained after a program of supervised resistance exercise in cancer patients with bone metastases: longitudinal results of a pilot study.

Authors:  Prue Cormie; Daniel A Galvão; Nigel Spry; David Joseph; Dennis R Taaffe; Robert U Newton
Journal:  Support Care Cancer       Date:  2014-01-15       Impact factor: 3.603

9.  BMP9 regulates cross-talk between breast cancer cells and bone marrow-derived mesenchymal stem cells.

Authors:  Shaoheng Wan; Yuehong Liu; Yaguang Weng; Wei Wang; Wei Ren; Chang Fei; Yingying Chen; Zhihui Zhang; Ting Wang; Jinshu Wang; Yayun Jiang; Lan Zhou; Tongchuan He; Yan Zhang
Journal:  Cell Oncol (Dordr)       Date:  2014-09-11       Impact factor: 6.730

10.  Factors related to incomplete treatment of breast cancer in Kumasi, Ghana.

Authors:  Mark Obrist; Ernest Osei-Bonsu; Baffour Awuah; Shinobu Watanabe-Galloway; Sofia D Merajver; Kendra Schmid; Amr S Soliman
Journal:  Breast       Date:  2014-10-01       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.